Literature DB >> 1943113

Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity.

R Hamazoe1, M Maeta, A Murakami, H Yamashiro, N Kaibara.   

Abstract

We analyzed heating profiles from 318 hyperthermic treatments of 39 patients with recurrent or inoperable cancers of the digestive organs whose deep-seated tumors were treated by radiofrequency (RF) capacitive heating of the abdominal region, and we investigated the heating efficiency and antitumor effect of such treatment. It was apparent that heating with a mean maximum RF output of 1,000 watts (700 watts at least), repeated four times or more, was necessary for a high rate of response by the tumor. Although it was difficult to heat tumors of the bile duct/pancreas to 42 degrees C or more, there was a strong positive correlation between maximum output of RF energy and maximum temperature of tumors (r = 0.839, P less than 0.001). The antitumor effect of RF hyperthermia was augmented with increasing output of RF energy. Therefore, the maximum level of RF output may be a useful index for expressing the heating efficiency with respect to intra-abdominal deep-seated tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943113     DOI: 10.1002/jso.2930480307

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial.

Authors:  M H Chung; T F Wood; G J Tsioulias; D M Rose; A J Bilchik
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

2.  Surrounding rim formation and reduction in size after radiofrequency ablation for primary breast cancer.

Authors:  Takeshi Nagashima; Masahiro Sakakibara; Takafumi Sangai; Toshiki Kazama; Hiroshi Fujimoto; Masaru Miyazaki
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

3.  Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine.

Authors:  Jason C Ho; Lam Nguyen; Justin J Law; Matthew J Ware; V Keshishian; N C Lara; Trac Nguyen; Steven A Curley; Stuart J Corr
Journal:  IEEE J Transl Eng Health Med       Date:  2017-04-03       Impact factor: 3.316

4.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

Authors:  E J Patterson; C H Scudamore; D A Owen; A G Nagy; A K Buczkowski
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

5.  Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience.

Authors:  M Lloret; L García-Cabrera; A Hernandez; N Santana; L López-Molina; P C Lara
Journal:  Clin Transl Oncol       Date:  2019-05-17       Impact factor: 3.405

Review 6.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

7.  Long-term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis: report of a case.

Authors:  S Otani; M Maeta; A Oka; Y Hirooka; S Tsujitani; M Ikeguchi; R Hamazoe; N Kaibara
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Radiofrequency ablation-assisted liver resection: review of the literature and our experience.

Authors:  Peng Yao; David L Morris
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

9.  Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience.

Authors:  Takayuki Ohguri; Hajime Imada; Katsuya Yahara; Hiroyuki Narisada; Tomoaki Morioka; Keita Nakano; Yukunori Korogi
Journal:  Radiat Med       Date:  2009-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.